Structured evidence table for Policosanol Cholesterol Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Policosanol Cholesterol Randomized Trial | It is concluded that oral administration of policosanol 20 mg/day for twelve weeks significantly lowered SBP and DBP in Cuban patients with grade I hypertension, and improved lipid profile variables, being safe and well tolerated. | 2 | Revueltas Aguero M (2025) | Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study. |
| Policosanol Cholesterol Randomized Trial | This study aimed to report the effects of policosanol (20 mg/day) on blood pressure values in Cuban patients with grade I hypertension. | 2 | Revueltas Aguero M (2025) | Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study. |
| Policosanol Cholesterol Randomized Trial | A double-blind multicenter trial randomized 400 eligible patients divided into two strata of patients with either prehypertension or grade I hypertension (200 patients each) treated with either placebo or policosanol 20 mg/day (100 patients/group/stratum) for 12 weeks. | 2 | Revueltas Aguero M (2025) | Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study. |
| Policosanol Cholesterol Randomized Trial | 1 2 Hypertension is the most frequent modifiable cardiovascular risk factor, with more than 1 billion individuals living with high blood pressure worldwide []. | 2 | Revueltas Moura (2025) | Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study |
| Policosanol Cholesterol Randomized Trial | 3 Evidence has proven the impact of lowering blood pressure for improving cardiovascular outcomes and all‐cause mortality [], making clear the relevance of promoting knowledge, prevention, and treatment of high blood pressure levels. | 2 | Revueltas Moura (2025) | Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study |
| Policosanol Cholesterol Randomized Trial | All guidelines agree that at the prehypertension stage, doctors may choose to initially manage hypertension with lifestyle changes only but may add medication based on the patient's overall cardiovascular risk. | 2 | Revueltas Moura (2025) | Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study |
| Policosanol Cholesterol Randomized Trial | Hypertension has been widely recognized as the leading cause of cardiovascular disease and the main contributor of global mortality []. | 2 | Revueltas Moura (2025) | Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study |
Source documents